Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real-World Use of Molnupiravir in the Treatment of Outpatients with SARS-CoV-2 Infection—A Patient Profile Based on the Experience of a Tertiary Infectious Disease Center
Adrian Streinu‐Cercel, Victor Daniel Miron, Alina Alexandra Oană, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1065-1065
Open Access | Times Cited: 10

Showing 10 citing articles:

Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants
Divya Teli, Pankti C. Balar, Kishan Patel, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 309-309
Open Access | Times Cited: 26
The race for clinical trials on Omicron-based COVID-19 vaccine candidates: Updates from global databases
Sandro G. Viveiros-Rosa, Cristina DS. Mendes, Galo Guillermo Farfán-Cano, et al.
Narra J (2022) Vol. 2, Iss. 3, pp. e88-e88
Open Access | Times Cited: 26
Therapeutic developments for SARS-CoV-2 infection—Molecular mechanisms of action of antivirals and strategies for mitigating resistance in emerging variants in clinical practice
Oana Săndulescu, Cătălin Apostolescu, Liliana Preoțescu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 9
Early Access to Oral Antivirals in High-Risk Outpatients: Good Weapons to Fight COVID-19
Giuseppe Bruno, Massimo Giotta, Serena Perelli, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2514-2514
Open Access | Times Cited: 13
The Incidence and Characteristics of Oral Candidiasis in Patients Hospitalized for SARS-CoV-2 Infection During the Circulation of Alpha, Beta, and Delta Variants
Elena Camelia Kouris, Sînziana Irina Mirea, Monica Luminos, et al.
Microorganisms (2024) Vol. 12, Iss. 10, pp. 2090-2090
Open Access | Times Cited: 1
Comparison of the acceptability and safety of molnupiravir in COVID-19 patients aged over and under 80 years
Kohei Fujita, Osamu Kanai, Hiroaki Hata, et al.
Aging and Health Research (2023) Vol. 3, Iss. 2, pp. 100130-100130
Open Access | Times Cited: 3
Molnupiravir Real-World Utilization in COVID-19 Patients in the Czech Republic
Pavel Dlouhý, Cyril Mucha, Lenka Mokrá, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2303-2303
Open Access
Real-World Utilization of Molnupiravir during the COVID-19 Omicron Surge in Israel
Clara Weil, Tobias Bergroth, Anna Eisenberg, et al.
Epidemiologia (2023) Vol. 4, Iss. 3, pp. 309-321
Open Access | Times Cited: 1
Molnupiravir

Reactions Weekly (2023) Vol. 1962, Iss. 1, pp. 269-269
Closed Access
Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial
Yayun Liu, Shiyong Fan, Aijing Xu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access
Page 1

Scroll to top